2292U |
n-Hexane Exposure Monitoring, Urine |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3103B |
Nadolol, Blood |
3103SP |
Nadolol, Serum/Plasma |
3103U |
Nadolol, Urine |
3107B |
Nabumetone as Metabolite, Blood |
3107SP |
Nabumetone as Metabolite, Serum/Plasma |
3107U |
Nabumetone as Metabolite, Urine |
3110B |
Nalbuphine - Free (Unconjugated), Blood |
3110SP |
Nalbuphine - Free (Unconjugated), Serum/Plasma |
3110U |
Nalbuphine - Total (Conjugated/Unconjugated), Urine |
3111B |
Naloxone - Free (Unconjugated), Blood |
3111SP |
Naloxone - Free (Unconjugated), Serum/Plasma |
3111U |
Naloxone - Total (Conjugated/Unconjugated), Urine |
3113U |
Naloxone - Total (Conjugated/Unconjugated) Screen, Urine |
3116B |
Naltrexone and Metabolite - Free (Unconjugated), Blood |
3116SP |
Naltrexone and Metabolite - Free (Unconjugated), Serum/Plasma |
3116U |
Naltrexone and Metabolite - Total (Conjugated/Unconjugated), Urine |
3118B |
Nateglinide, Blood |
3118SP |
Nateglinide, Serum/Plasma |
3130B |
Naproxen, Blood |
3130FL |
Naproxen, Fluid |
3130SP |
Naproxen, Serum/Plasma |
3130U |
Naproxen, Urine |
3140B |
Nickel, Blood |
3140FL |
Nickel, Fluid |
3140H |
Nickel, Hair |
3140N |
Nickel, Nails |
3140R |
Nickel, RBCs |
3140SP |
Nickel, Serum/Plasma |
3140TI |
Nickel, Tissue |
3140U |
Nickel, Urine |
3145B |
Nefazodone, Blood |
3145SP |
Nefazodone, Serum/Plasma |
3145U |
Nefazodone, Urine |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3158B |
Nifedipine, Blood |
3158SP |
Nifedipine, Serum/Plasma |
3174B |
Nitrate/Nitrite (Qualitative), Blood (Forensic) |
3174SP |
Nitrate/Nitrite (Qualitative), Serum/Plasma |
3175B |
Nitrazepam and Metabolite, Blood |
3175SP |
Nitrazepam and Metabolite, Serum/Plasma |
3175U |
Nitrazepam and Metabolite, Urine |
3214B |
Nitrous Oxide, Blood |
3214TI |
Nitrous Oxide, Tissue |
3216B |
Nordiazepam and Metabolite, Blood |
3216SP |
Nordiazepam and Metabolite, Serum/Plasma |
3216U |
Nordiazepam and Metabolite, Urine |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3220B |
Nortriptyline, Blood |
3220SP |
Nortriptyline, Serum/Plasma |
3220TI |
Nortriptyline, Tissue |
3220U |
Nortriptyline, Urine |
3223SP |
Nonsteroidal Anti-Inflammatory Drug Panel, Serum/Plasma |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3225SP |
Nuedexta®, Serum/Plasma |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) |
8702B |
Nortriptyline, Blood |
8702U |
Nortriptyline, Urine |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
9215B |
Nitrazepam and Metabolite Screen, Blood |
9215SP |
Nitrazepam and Metabolite Screen, Serum/Plasma |
9404B |
Nicotine and Metabolite Screen, Blood |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |
9433B |
Nortriptyline Screen, Blood |
9433U |
Nortriptyline Screen, Urine |